NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Executive Compensation
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) is a publicly traded company on the Nasdaq, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NAII
CIK: 787253
Exchange: Nasdaq
SIC 2833: Medicinal Chemicals & Botanical Products
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 6/30/2017 12:00:00 AM
Lead Engagement PartnerWayne Pinnell
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-K | 2026-09-28 | 2026-06-30 | FORM 10-K | 0001437749-26-031343 | View SEC Doc Filr Page |
| S-8 | 2026-05-21 | — | FORM S-8 | 0001437749-26-018078 | View SEC Doc Filr Page |
| 10-Q | 2026-05-19 | 2026-03-31 | FORM 10-Q | 0001437749-26-017684 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-18 | 2026-03-31 | FORM NT 10-Q | 0001437749-26-017638 | View SEC Doc Filr Page |
| 8-K | 2026-05-01 | 2026-04-28 | FORM 8-K | 0001437749-26-014497 | View SEC Doc Filr Page |
| 8-K | 2026-03-20 | 2026-03-18 | FORM 8-K | 0001437749-26-009247 | View SEC Doc Filr Page |
| 4 | 2026-03-10 | 2026-03-06 | FORM 4 | 0001437749-26-007620 | View SEC Doc Filr Page |
| 4 | 2026-03-10 | 2026-03-06 | FORM 4 | 0001437749-26-007619 | View SEC Doc Filr Page |
| 4 | 2026-03-10 | 2026-03-06 | FORM 4 | 0001437749-26-007618 | View SEC Doc Filr Page |
| 4 | 2026-03-10 | 2026-03-06 | FORM 4 | 0001437749-26-007515 | View SEC Doc Filr Page |
| 4 | 2026-03-10 | 2026-03-06 | FORM 4 | 0001437749-26-007514 | View SEC Doc Filr Page |
| 4 | 2026-03-10 | 2026-03-06 | FORM 4 | 0001437749-26-007513 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-04 | FORM 4 | 0001437749-26-007255 | View SEC Doc Filr Page |
| 4 | 2026-03-03 | 2026-02-27 | FORM 4 | 0001437749-26-006754 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-25 | FORM 4 | 0001437749-26-006139 | View SEC Doc Filr Page |
| 4 | 2026-02-24 | 2026-02-20 | FORM 4 | 0001437749-26-005423 | View SEC Doc Filr Page |
| 4 | 2026-02-20 | 2026-02-17 | FORM 4 | 0001437749-26-004935 | View SEC Doc Filr Page |
| 10-Q | 2026-02-13 | 2025-12-31 | FORM 10-Q | 0001437749-26-004118 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-01-21 | — | SCHEDULE 13G/A Filing | 0000354204-26-000331 | View SEC Doc Filr Page |
| 4 | 2026-01-05 | 2025-12-23 | FORM 4 | 0001437749-26-000287 | View SEC Doc Filr Page |
| 8-K | 2025-12-17 | 2025-12-17 | FORM 8-K | 0001437749-25-038181 | View SEC Doc Filr Page |
| 8-K | 2025-12-12 | 2025-12-05 | FORM 8-K | 0001437749-25-037601 | View SEC Doc Filr Page |
| 10-Q | 2025-11-12 | 2025-09-30 | FORM 10-Q | 0001437749-25-034473 | View SEC Doc Filr Page |
| DEF 14A | 2025-10-23 | 2025-12-05 | FORM DEF 14A | 0001437749-25-031627 | View SEC Doc Filr Page |
| 10-K | 2025-09-23 | 2025-06-30 | FORM 10-K | 0001437749-25-029731 | View SEC Doc Filr Page |